Financial Summary (All financials)
| In millions of CNY, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 5,825.6 | 4,647.5 | 2,561.2 | 873.2 | 312.6 |
| Revenue growth | 25.3% | 81.5% | 193.3% | 179.4% | |
| Cost of goods sold | 4,742.7 | 3,565.1 | 1,843.4 | 598.0 | 232.5 |
| Gross profit | 1,083.0 | 1,082.4 | 717.8 | 275.2 | 80.0 |
| Gross margin | 18.6% | 23.3% | 28.0% | 31.5% | 25.6% |
| Sales and marketing | 597.2 | 529.2 | 379.6 | 95.3 | 20.9 |
| EBIT | 215.9 | 337.2 | 89.2 | 701.4 | 247.3 |
| EBIT margin | 3.7% | 7.3% | 3.5% | 80.3% | 79.1% |
| Pre-tax income | 217.8 | 339.0 | 89.4 | 108.0 | 14.0 |
| Income taxes | 43.3 | 45.2 | 24.1 | 14.7 | -2.2 |
| Tax rate | 19.9% | 13.3% | 26.9% | 13.6% | |
| Net income | 173.3 | 292.2 | 65.4 | 93.2 | 16.3 |
| Net margin | 3.0% | 6.3% | 2.6% | 10.7% | 5.2% |
| |
| Diluted EPS | $0.85 | $1.44 | $1.01 | $4.13 | $1.17 |
| Shares outstanding (diluted) | 215.6 | 215.9 | 79.6 | 25.6 | 12.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|